HFOV with Volume Guarantee in Pediatric Respiratory Failure
Consider HFOV with volume guarantee (HFOV-VG) when conventional mechanical ventilation fails in neonates and infants with severe respiratory failure, as it provides more stable ventilation with lower tidal volumes and reduced CO2 fluctuations compared to standard HFOV. 1
When to Use HFOV-VG
Indications
- Primary indication: Rescue therapy when conventional mechanical ventilation fails in neonates and infants 1
- Specific populations:
Contraindications
- Do not use in obstructive airway disease (applies to high-frequency jet ventilation specifically) 1
How to Apply HFOV-VG
Initial Settings
Target Tidal Volume (VThf):
- Use 1.4-2.5 mL/kg for adequate ventilation 3, 4
- Median effective volume in preterm RDS: 1.63 mL/kg (IQR 1.44-1.84) 3
- Keep VThf <2.5 mL/kg to avoid hypercapnia in most cases 4
- Lower volumes may be needed in lung hypoplasia syndromes 1
Frequency Selection:
- Use high frequencies (15-18 Hz) in preterm infants with RDS 3
- Higher frequencies allow adequate ventilation with lower tidal volumes 3
- Frequency inversely correlates with required tidal volume 3
Mean Airway Pressure (mPaw):
- Start with baseline mPaw of 10-13 cmH2O 5
- Perform lung recruitment maneuvers to identify optimal mPaw
- Critical opening pressure typically 12-16 cmH2O 5
- Optimal mPaw after recruitment typically 10-14 cmH2O 5
Amplitude Settings:
- Set maximum allowed amplitude 10 cmH2O above the usually required amplitude to maintain VThf during transport or position changes 4
Lung Recruitment Strategy
Use an open lung approach guided by oscillation pressure amplitude changes (ΔPhf) 5:
- Baseline assessment: Record initial ΔPhf at starting mPaw
- Progressive recruitment: Increase mPaw incrementally (typically 1-2 cmH2O steps)
- Monitor ΔPhf: A secondary spontaneous decrease in ΔPhf indicates successful lung recruitment 5
- Confirm with oxygenation: Improvement in SpO2/FiO2 ratio validates recruitment 5
- Set optimal mPaw: Typically 2 cmH2O below critical opening pressure 5
This approach provides earlier prediction of optimal lung recruitment compared to waiting for oxygenation changes alone 5.
Advantages Over Standard HFOV
HFOV-VG demonstrates superior outcomes 6:
- Increased survival free of moderate-to-severe BPD (OR 3.15,95% CI 1.66-5.98) in preterm infants <32 weeks 6
- Lower VThf fluctuations: Average VThf is lower and more stable 2
- Reduced CO2 variability: Significantly lower incidence of both hypocapnia and hypercapnia 2
- Shorter ventilation duration: Reduced time on invasive mechanical ventilation 2, 6
- Reduced workload: Fewer ventilator adjustments required per hour 2
- Potentially lower mortality and air leak syndrome 6
Monitoring Parameters
Essential monitoring during HFOV-VG:
- VThf: Continuously monitor to ensure it stays within target range
- ΔPhf: Watch for changes indicating lung volume status 5
- Blood gases: Arterial or capillary PCO2, pH (target pH >7.20) 1
- Oxygenation: SpO2 92-97% when PEEP <10 cmH2O; 88-92% when PEEP ≥10 cmH2O for PARDS 1
- Airway pressures: Peak, mean, and PEEP near Y-piece in infants <10 kg 1
Common Pitfalls and How to Avoid Them
Inadequate VThf delivery: In some cases, VThf may fall >0.38 mL/kg below target 4
- Solution: Set maximum amplitude limit 10 cmH2O above typical requirement 4
Using standard HFOV frequencies: Lower frequencies require higher tidal volumes
- Solution: Use high frequencies (15-18 Hz) to enable lower, safer tidal volumes 3
Delayed recognition of optimal lung recruitment: Waiting only for oxygenation changes
- Solution: Monitor ΔPhf for earlier identification of optimal mPaw 5
Excessive tidal volumes: Risk of volutrauma
Clinical Context
The 2017 Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) guidelines establish that HFOV should be considered when conventional ventilation fails 1. While these guidelines predate widespread HFOV-VG adoption, recent evidence from 2021-2025 demonstrates that adding volume guarantee to HFOV provides measurable benefits in neonatal populations 6. The most recent systematic review (2025) confirms that HFOV-VG increases survival free of moderate-to-severe BPD without reducing overall BPD incidence 6, representing a meaningful improvement in quality of life outcomes for preterm survivors.